Genesis Fertility Center Public Company (GFC) Fair Value & Analysis
Healthcare · TH · Market cap 546M THB
Fair value as of: Jun 24, 2026
From 24 valuation models · updated 5 days ago
Share price −10.8% over the past month.
Price vs Fair Value (12 months)
12‑month range 2.32 THB – 4.11 THB · fair‑value band 1.53 THB – 2.55 THB · the 2.32 THB price screens above the 2.04 THB fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Genesis Fertility Center Public Company (GFC) currently trades at 2.32 THB, while our model-based Fair Value estimate is 2.04 THB — implying the stock looks roughly 12.1% overvalued today. We read business quality at 90/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Genesis Fertility Center Public Company generated revenue of 330M THB at a net margin of 3.5%. Revenue declined 25.7% year over year. It earns a return on equity of 2.7%. Net debt stands at 98.2M THB. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Genesis Fertility Center Public Company Limited operates as a medical clinic focusing on treating infertility in Thailand. The company offers intracytoplasmic sperm injection (ICSI), in vitro fertilization (IVF), intrauterine insemination (IUI), frozen embryo transfer, egg freezing, and chromosomal screening services, as well as counseling services to infertile people. It is also involved in the provision of other businesses consulting and management investment services. Genesis Fertility Center Public Company Limited was founded in 2016 and is headquartered in Bangkok, Thailand.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Genesis Fertility Center Public Company reported revenue of 353M THB in FY2025 versus 242M THB in FY2021, a compound +9.9%/yr. Reported net income was 22.4M THB in FY2025, compounding −24.7%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$97.60 | R$115.75 | +19% |
| Fresenius SE FSNUY | $11.27 | $8.25 | -27% |
| 5225 5225 | 8.70 MYR | 2.61 MYR | -70% |
| IHHHF IHHHF | $1.71 | $1.26 | -26% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Genesis Fertility Center Public Company (GFC) undervalued?
What is the fair value of GFC?
What is the quality score of GFC?
What is the revenue of Genesis Fertility Center Public Company (GFC)?
What is the net profit margin of GFC?
Does Genesis Fertility Center Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.